Prescription Drug Program Provider Guide update


 

Provider Alert

Effective for dates of service on and after January 1, 2015, the Health Care Authority (agency) will pay fee-for-service for immune modulators and anti-viral medications used to treat chronic Hepatitis C virus (HCV) infection, rather than through the client’s managed care plan. When billing for these medications, bill the agency directly. The agency has updated the Prescription Drug Program Provider Guide to reflect this change in policy.